Mindray Medical (??????????), the Shenzhen-based medical device maker, reported positive results for its Q4 and full-year 2008. Revenues climbed to $547.4 million, which represented a 61% increase in China and a 110% improvement in international markets. Non-GAAP income rose 50% to $132.7 million. Although Mindray’s numbers were healthy, investors seemed unhappy that the company’s overall business did not grow more rapidly. More details...

Stock Symbol: (NYSE: MR) (NSDQ: DSCP)

Mindray Medical International Limited (??????????) reported preliminary 2008 results for its medical device business, showing that the company continued to perform well, despite the difficult economic environment. Mindray expects 2008 revenues to be in the range of $540 million to $550 million, an 85% jump. For net income, Mindray is predicting non-GAAP EPS will be at least $1.16, a 47% increase over the 2007 figure. More details...

Stock Symbols: (NYSE: MR) (NSDQ: DSCP)